epocrates logo
epocrates logo
epocrates logo
  • 0

Journal Article Synopsis

J Psychopharmacol

Antidepressant effectiveness may diminish after treatment interruption

September 17, 2025

card-image

Study details: This systematic review included 12 studies (N = 594) across psychiatric conditions, examining loss of antidepressant efficacy after treatment interruption and reinitiation. Studies were included regardless of language or publication date.

Results: Non-response rates ranged from 4% to 57%. Many patients who'd previously responded to antidepressants failed to regain efficacy after a drug-free interval, suggesting that intermittent use or cycling may impair future treatment response.

Clinical impact: Interrupting antidepressant therapy may reduce the likelihood of future responsiveness, contributing to persistent depression despite rising prescription rates. Consider discussing these risks with patients, as reinitiation may not reliably restore prior benefit.

Source:

Majkic N, et al. (2025, September 13). J Psychopharmacol. Loss of responsiveness on reinstatement of antidepressants after treatment interruption - A systematic review. https://pubmed.ncbi.nlm.nih.gov/40944456/

Trending icon

TRENDING THIS WEEK

EPOCRATES CME

View Catalog

view all CME activities
learn more about epocrates plus
Clinical FAQ icon

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information